A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases

NCT07212322 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus
Idiopahic Inflammatory Myopathies
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Sjögren's Syndrome
Antiphospholipid Syndrome
Immune Thrombocytopenia
Systemic Sclerosis

Interventions

DRUG: CD19 UCAR-T cells

Sponsor

Institute of Hematology & Blood Diseases Hospital, China